Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Markus Pfirrmann"'
Autor:
Philipp J. Jost, Gabriele Prange-Krex, Wolfgang Seifarth, Tim H. Brümmendorf, Martin Müller, Joelle Guilhot, Robert Eckert, Susanne Saussele, Christian Dietz, Cornelius F. Waller, Carsten Janβen, Birgit Spiess, Viktor Janzen, Gerd Büschel, Sebastien Rinaldetti, Philippe Schafhausen, Markus Pfirrmann, Stefan Hanzel, Martine Klausmann, Panayiotidis Panagiotidis, Jolanta Dengler, Kirsi Manz, Maria Elisabeth Goebeler, Maria Pagoni, Regina Herbst, Wolf-Karsten Hofmann, Thomas Illmer, Maria Dimou, Alice Fabarius, Alexander Kiani, Andreas Burchert, Francois-Xavier Mahon
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:266-271
Within the EURO-SKI trial, 132 chronic phase CML patients discontinued imatinib treatment. RNA was isolated from peripheral blood in order to analyze the expression of MDR1, ABCG2 and OCT1. ABCG2 was predictive for treatment-free remission in Cox reg
Autor:
Markus, Pfirrmann, Gerhard, Ehninger, Christian, Thiede, Martin, Bornhäuser, Michael, Kramer, Christoph, Röllig, Joerg, Hasford, Markus, Schaich, L, Greiner
Publikováno v:
The Lancet Oncology. 13:207-214
The optimum post-remission treatment (PRT) in acute myeloid leukaemia (AML) is still a matter of debate. Consolidation treatments include chemotherapy with high-dose cytarabine, or allogeneic or autologous haemopoietic stem cell transplantation (HSCT
Autor:
P. Panayiotidis, Cornelius F. Waller, Birgit Spiess, Mahon Fx, Susanne Saussele, Jolanta Dengler, C. Sticht, G. Freunek, Daniel Nowak, Markus Pfirrmann, Wolfgang Seifarth, T H Brümmendorf, Alice Fabarius, W-K. Hofmann, Maria Pagoni, R. Sebastien, M. Dimou, Andreas Burchert
Publikováno v:
Annals of Oncology. 28:v367
Autor:
Markus Pfirrmann, Bruno Reichart, Mechthild Stoeckelhuber, Markus Rehm, J.-M. Abicht, Bernhard F. Becker, Joern O. Paul, Dirk Bruegger, Frank Christ
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 138(6):1445-1447
A healthy vascular endothelium is coated by the endothelial glycocalyx. Its main constituents are transmembrane syndecans and bound heparan sulfates. In vivo the glycocalyx binds plasma proteins, forming the endothelial surface layer, which has a thi